---
figid: PMC8120466__ijbsv17p1671g006
figtitle: MUC3A induces PD-L1 and reduces tyrosine kinase inhibitors effects in EGFR-mutant
  non-small cell lung cancer
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC8120466
filename: ijbsv17p1671g006.jpg
figlink: /pmc/articles/PMC8120466/figure/F6/
number: F6
caption: Schematic model proposed for the role of MUC3A inducing PD-L1 and reducing
  TKI effects in EGFR-mutant NSCLC. MUC3A induced PD-L1 via PI3K/AKT and MAPK pathway.
  MEK and PI3K inhibitors (trametinib and pictilisib) blocked EGF-induced PD-L1 expression.
  TKIs (AZD-9291) inhibited the cell proliferation.
papertitle: MUC3A induces PD-L1 and reduces tyrosine kinase inhibitors effects in
  EGFR-mutant non-small cell lung cancer.
reftext: Yuan Luo, et al. Int J Biol Sci. 2021;17(7):1671-1681.
year: '2021'
doi: 10.7150/ijbs.57964
journal_title: International Journal of Biological Sciences
journal_nlm_ta: Int J Biol Sci
publisher_name: Ivyspring International Publisher
keywords: MUC3A | non-small cell lung cancer | EGFR | PD-L1.
automl_pathway: 0.9651145
figid_alias: PMC8120466__F6
figtype: Figure
redirect_from: /figures/PMC8120466__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8120466__ijbsv17p1671g006.html
  '@type': Dataset
  description: Schematic model proposed for the role of MUC3A inducing PD-L1 and reducing
    TKI effects in EGFR-mutant NSCLC. MUC3A induced PD-L1 via PI3K/AKT and MAPK pathway.
    MEK and PI3K inhibitors (trametinib and pictilisib) blocked EGF-induced PD-L1
    expression. TKIs (AZD-9291) inhibited the cell proliferation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD274
  - EGF
  - SEA
  - MST1R
  - SLC25A1
  - EGFR
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - MUC3A
  - MUC3B
---
